102 related articles for article (PubMed ID: 24316050)
1. Acetylsalicylic acid therapy: influence of metformin use and other variables on urinary 11-dehydrothromboxane B2 levels.
Gonçalves LH; Silva MV; Duarte RC; Dusse LM; Fernandes AP; Bosco AA; Gomes KB; Carvalho Md
Clin Chim Acta; 2014 Feb; 429():76-8. PubMed ID: 24316050
[TBL] [Abstract][Full Text] [Related]
2. Predictors of high platelet reactivity during aspirin treatment in patients with type 2 diabetes.
Kapłon-Cieślicka A; Rosiak M; Postuła M; Serafin A; Kondracka A; Opolski G; Filipiak KJ
Kardiol Pol; 2013; 71(9):893-902. PubMed ID: 24065375
[TBL] [Abstract][Full Text] [Related]
3. Aspirin insensitive thromboxane generation is associated with oxidative stress in type 2 diabetes mellitus.
Ames PR; Batuca JR; Muncy IJ; De La Torre IG; Pascoe-Gonzales S; Guyer K; Matsuura E; Lopez LR
Thromb Res; 2012 Sep; 130(3):350-4. PubMed ID: 22521214
[TBL] [Abstract][Full Text] [Related]
4. Urinary 11-dehydro thromboxane B₂ levels in type 2 diabetic patients before and during aspirin intake.
Gonçalves LH; Dusse LM; Fernandes AP; Gomes KB; Sóter MO; Alves MT; Rodrigues KF; Freitas FR; Komatsuzaki F; Sousa MO; Bosco AA; Pianett GA; Carvalho Md
Clin Chim Acta; 2011 Jul; 412(15-16):1366-70. PubMed ID: 21510926
[TBL] [Abstract][Full Text] [Related]
5. Decreased in vivo oxidative stress and decreased platelet activation following metformin treatment in newly diagnosed type 2 diabetic subjects.
Formoso G; De Filippis EA; Michetti N; Di Fulvio P; Pandolfi A; Bucciarelli T; Ciabattoni G; Nicolucci A; Davì G; Consoli A
Diabetes Metab Res Rev; 2008; 24(3):231-7. PubMed ID: 17966969
[TBL] [Abstract][Full Text] [Related]
6. The inhibitory effect of statins on urinary 11-dehydrothromboxane levels.
Alusik S; Paluch Z; Lejsková M; Adámek T
Int Angiol; 2010 Jun; 29(3):255-9. PubMed ID: 20502413
[TBL] [Abstract][Full Text] [Related]
7. Reduced blood platelet sensitivity to aspirin in coronary artery disease: are dyslipidaemia and inflammatory states possible factors predisposing to sub-optimal platelet response to aspirin?
Markuszewski L; Rosiak M; Golanski J; Rysz J; Spychalska M; Watala C
Basic Clin Pharmacol Toxicol; 2006 May; 98(5):503-9. PubMed ID: 16635110
[TBL] [Abstract][Full Text] [Related]
8. Association of plasma concentrations of salicylic acid and high on ASA platelet reactivity in type 2 diabetes patients.
Postula M; Janicki PK; Rosiak M; Przybylkowski A; Kaplon-Cieslicka A; Grygorowicz T; Trzepla E; Filipiak KJ; Czlonkowski A; Opolski G
Cardiol J; 2013; 20(2):170-7. PubMed ID: 23558875
[TBL] [Abstract][Full Text] [Related]
9. Incomplete inhibition of thromboxane biosynthesis by acetylsalicylic acid: determinants and effect on cardiovascular risk.
Eikelboom JW; Hankey GJ; Thom J; Bhatt DL; Steg PG; Montalescot G; Johnston SC; Steinhubl SR; Mak KH; Easton JD; Hamm C; Hu T; Fox KA; Topol EJ;
Circulation; 2008 Oct; 118(17):1705-12. PubMed ID: 18838564
[TBL] [Abstract][Full Text] [Related]
10. Differential Impact of Serial Measurement of Nonplatelet Thromboxane Generation on Long-Term Outcome After Cardiac Surgery.
Kakouros N; Gluckman TJ; Conte JV; Kickler TS; Laws K; Barton BA; Rade JJ
J Am Heart Assoc; 2017 Nov; 6(11):. PubMed ID: 29097390
[TBL] [Abstract][Full Text] [Related]
11. Serum Brain-Derived Neurotrophic Factor is Related to Platelet Reactivity and Metformin Treatment in Adult Patients With Type 2 Diabetes Mellitus.
Eyileten C; Mirowska-Guzel D; Milanowski L; Zaremba M; Rosiak M; Cudna A; Kaplon-Cieslicka A; Opolski G; Filipiak KJ; Malek L; Postula M
Can J Diabetes; 2019 Feb; 43(1):19-26. PubMed ID: 29891331
[TBL] [Abstract][Full Text] [Related]
12. Direct comparison among oral hypoglycemic agents and their association with insulin resistance evaluated by euglycemic hyperinsulinemic clamp: the 60's study.
Derosa G; Maffioli P; Salvadeo SA; Ferrari I; Gravina A; Mereu R; Palumbo I; D'Angelo A; Cicero AF
Metabolism; 2009 Aug; 58(8):1059-66. PubMed ID: 19394976
[TBL] [Abstract][Full Text] [Related]
13. The effect of doubling the dose of acetylsalicylic acid (ASA) on platelet function parameters in patients with type 2 diabetes and platelet hyperreactivity during treatment with 75 mg of ASA: a subanalysis of the AVOCADO study.
Rosiak M; Postuła M; Kapłon-Cieślicka A; Trzepla E; Filipiak KJ; Członkowski A; Opolski G
Kardiol Pol; 2013; 71(6):552-7. PubMed ID: 23797426
[TBL] [Abstract][Full Text] [Related]
14. The combined effect of metformin and L-cysteine on inflammation, oxidative stress and insulin resistance in streptozotocin-induced type 2 diabetes in rats.
Salman ZK; Refaat R; Selima E; El Sarha A; Ismail MA
Eur J Pharmacol; 2013 Aug; 714(1-3):448-55. PubMed ID: 23845213
[TBL] [Abstract][Full Text] [Related]
15. Effect of metformin on intact proinsulin and des 31,32 proinsulin concentrations in subjects with non-insulin-dependent (type 2) diabetes mellitus.
Nagi DK; Ali VM; Yudkin JS
Diabet Med; 1996 Aug; 13(8):753-7. PubMed ID: 8862952
[TBL] [Abstract][Full Text] [Related]
16. Association of insulin resistance with hyperglycemia in streptozotocin-diabetic pigs: effects of metformin at isoenergetic feeding in a type 2-like diabetic pig model.
Koopmans SJ; Mroz Z; Dekker R; Corbijn H; Ackermans M; Sauerwein H
Metabolism; 2006 Jul; 55(7):960-71. PubMed ID: 16784971
[TBL] [Abstract][Full Text] [Related]
17. [Effect of metformin on the expression of tumor necrosis factor-α, Toll like receptors 2/4 and C reactive protein in obese type-2 diabetic patients].
Andrews M; Soto N; Arredondo M
Rev Med Chil; 2012 Nov; 140(11):1377-82. PubMed ID: 23677182
[TBL] [Abstract][Full Text] [Related]
18. Metformin: diamonds are forever.
Papanas N; Maltezos E; Mikhailidis DP
Expert Opin Pharmacother; 2009 Oct; 10(15):2395-7. PubMed ID: 19678795
[TBL] [Abstract][Full Text] [Related]
19. Effect of acetylsalicylic acid on platelet activation and oxidative profile in a set of Brazilian patients with type 2 diabetes mellitus.
Duarte RC; Gonçalves LH; Campos FM; Filho OA; Alves MT; Fernandes AP; Borges KB; Dusse LM; Faria MC; Gonçalves GS; Bosco AA; Sandrim VC; Carvalho MG
Blood Coagul Fibrinolysis; 2015 Mar; 26(2):123-30. PubMed ID: 25325344
[TBL] [Abstract][Full Text] [Related]
20. Thromboxane-dependent CD40 ligand release in type 2 diabetes mellitus.
Santilli F; Davì G; Consoli A; Cipollone F; Mezzetti A; Falco A; Taraborelli T; Devangelio E; Ciabattoni G; Basili S; Patrono C
J Am Coll Cardiol; 2006 Jan; 47(2):391-7. PubMed ID: 16412866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
